For longer-duration data, were still waiting, but the available evidence supports a favorable safety profile for chronic use in appropriately selected patients
PAPs are typically sponsored by pharmaceutical companies and help individuals with low incomes, uninsured, or underinsured access medications at no cost or with discounts
Employers rarely get in the weeds on what individual drugs their plans cover, Backus said, but obesity drugs are so popular and expensive that they can be an exception, so companies need to be careful. Theres just been so much activity under 1557, and I just wonder what else might be coming, she said
PIONEER-2 trial emulation with real-world data Diabetes, Obesity & Metabolism
More than half of all live births in the United States from 2022 to 2024 were to women 30 and over, according to March of Dimes
[25] Regular monitoring of electrolyte levels may be warranted in patients receiving these combinations